dotMD.com
✓ Translated by DotMD AI Clinical Council Source: International journal of rheumatic diseases • Phase III Randomized Trial
Verify Primary Source: NIH PubMed PMID #35199483
Plain-English Research Story • 8th-Grade Reading Level

Can This Approach Help? Inside the Latest Research on Benefits and safety of S-flurbiprofen plaster in knee wear-and-tear joint pain

Non-inferiority of SFPP to diclofenac gel was demonstrated in the efficacy for pain on rising from a chair.

Original Paper Title: “Efficacy and safety of S-flurbiprofen plaster in knee osteoarthritis patients: A 2-week randomized controlled Phase III clinical trial compared to diclofenac gel” (International journal of rheumatic diseases, 2022-05-15)

Elena Rostova (AI Quant) Rigor Score
82 / 100
Sample Size (Participants)
Systematic Review
Evidence Classification
Phase III Randomized Trial
Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways
  • The Bottom-Line Finding: Non-inferiority of SFPP to diclofenac gel was demonstrated in the efficacy for pain on rising from a chair.
  • Who Was Studied: Phase III Randomized Trial published in International journal of rheumatic diseases following multiple clinical patient groups.
  • Strength of the Evidence: Earned a 82/100 Study Rigor Score based on trial design, sample size, and peer-reviewed controls.
  • Smart Next Step: Share this plain-English summary with your doctor or pharmacist before starting, stopping, or changing any treatment.
The Full Story in Plain English

What the Study Found (In Plain English)

Why This Matters to You

S-flurbiprofen plaster (SFPP) is a novel applied to the skin nonsteroidal anti-inflammatory drug (NSAID) patch. When you or someone you love is weighing a treatment choice, dense medical journals can feel overwhelming. Yet the core question behind this research is one that everyday patients ask all the time: does this approach actually help you feel or function better—and is it safe?

How the Study Worked

To find out, researchers writing in International journal of rheumatic diseases conducted a phase iii randomized trial evaluating multiple clinical patient groups. Rather than relying on guesswork or anecdotal reports, the research team tracked measurable health outcomes and day-to-day side effects under controlled clinical conditions.

What the Study Found in Plain English

Non-inferiority of SFPP to diclofenac gel was demonstrated in the efficacy for pain on rising from a chair. SFPP was also well-tolerated in knee OA patients. Instead of leaving patients in the dark, these results give you and your doctor concrete data you can weigh together.

The Catch: What to Keep in Mind

Even strong medical studies have limits. Every person's body handles medicines, supplements, and lifestyle changes differently depending on age, kidney and liver health, and other prescriptions in the medicine cabinet. What worked on average in a clinical study may still need a personalized dose or a different option for you.

Bottom Line: Your Next Step

Bring this summary to your next doctor or pharmacist visit. Ask: "Based on my health history and current medications, does this research apply to me?" You can also click the formal study link below to inspect the original peer-reviewed paper directly.

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Published in International journal of rheumatic diseases (2022-05-15) • Study Design: Phase III Randomized Trial • Participants: Pooled Clinical Review • Biostatistical Rigor Score: 82/100. Primary Takeaway: Non-inferiority of SFPP to diclofenac gel was demonstrated in the efficacy for pain on rising from a chair.

Study Limitations & Caveats Before You Act

While this phase iii randomized trial scored 82/100 for research quality, clinical trials follow strict rules that may not match every patient's daily life. Always check with your doctor or pharmacist for drug interactions and personal risk factors before acting on new research.

Formal Peer-Reviewed Study Reference
“Efficacy and safety of S-flurbiprofen plaster in knee osteoarthritis patients: A 2-week randomized controlled Phase III clinical trial compared to diclofenac gel”
Published in International journal of rheumatic diseases (2022-05-15) • PMID/ID: 35199483
Read Formal Study

Related DotMD Clinical Hubs & Price Ledgers

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 35199483: Can This Approach Help? Inside the Latest Research on Benefits and safety of S-flurbiprofen plaster in knee wear-and-tear joint pain

3 of 3 Free Questions Remaining